平安健康2024年中期業績:公司首次盈利上岸,戰略業務同比增長19.7%
8月20日,平安健康醫療科技有限公司(股票簡稱"平安好醫生",1833.HK,以下簡稱"平安健康"或"公司")發佈2024年中期業績公吿。
報吿期內,公司營收20.9億元,首次扭虧為盈實現盈利超6000萬,調整後淨利潤為近9000萬。其中,戰略業務收入同比增長19.7%,實現穩健增長,保險及金融客户端(以下簡稱F端)的服務收入11.2億元,同比增長3.4%,企業端(以下簡稱B端)的員工健康管理服務收入達7.1億元,同比大幅增長58.8%。
平安健康作為平安集團醫療養老生態圈的旗艦,堅定踐行管理式醫療戰略,持續深化醫險協同,升級分層服務能力,實現F端收入及用户數雙增長,上半年付費用户數約1480萬,同比增長7%。同時,企業健康管理是公司戰略2.0深化的又一重要戰略佈局,也是公司長期增長的核心驅動力。隨着對平安集團企業客户滲透率的持續提升,以及自主拓展企業客户的不斷增長,企業端業務發展強勁,服務的企業客户數亦快速增長。截至報吿期末,累計服務的企業客户數達1748家,較去年同期增長46%,穩穩佔據市場領先地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.